跳至主要内容
临床试验/NCT04874285
NCT04874285已完成不适用

Supplementation With Hyaluronic Acid, Alpha-lipoic Acid, Magnesium, and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone: a Pilot Study.

Lo.Li.Pharma s.r.l1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2021年5月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
63
试验地点
1
主要终点
reduction of the abortion rate

研究概览

简要总结

The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Women with risk factor for abortion (sub-chorionic hematoma during gestation or ART procedures)

排除标准

  • •Other pregnancy-related conditions
  • •Diabetes or hypertension
  • •Concomitant pharmacological therapies (anticoagulant or antihypertensive)
  • •Use of tocolytic drugs two months prior to enrollment
  • •Association with hypoglycemic drugs

研究组 & 干预措施

control group

No Intervention

Women with risk factors for abortion, treated with progesterone

study group

Experimental

Women with risk factors for abortion, treated with progesterone and a dietary supplement containing hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6

干预措施: HA (Dietary Supplement)

结局指标

主要结局

reduction of the abortion rate

时间窗: 1 day (single time-point before week 20 of gestation)

rate of abortion

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验